Revian Laser Press Announcement

Revian Laser Press Announcement

New Research Offers Hope for Patients with Challenging Hair Loss Conditions

Hair loss can be difficult under any circumstance, but some conditions are especially complex to manage. One of the most challenging is central centrifugal cicatricial alopecia (CCCA), a form of scarring alopecia with limited treatment options.

New findings from Dr. Amy McMichael of Wake Forest University are offering renewed, evidence-based hope for patients navigating this diagnosis. Read more here.

Why CCCA Is So Difficult to Treat

CCCA is a progressive inflammatory condition that can permanently damage hair follicles if not addressed early. Until now, treatment options have focused primarily on managing inflammation rather than supporting regrowth.

That’s why recent research evaluating Revian® Red photobiomodulation therapy as part of a treatment regimen is generating attention in the hair loss community.

What the Research Found

In Dr. McMichael’s evaluation of Revian use in patients with CCCA:

  • 61% of participants experienced a reduction in inflammation
  • Just over 50% observed improvements in hair density

While Revian is not presented as a cure, these findings represent meaningful progress for a condition that has historically been very difficult to manage.

How Revian Works

Revian uses targeted red-light therapy designed to:

  • Reduce inflammation
  • Support scalp health
  • Improve cellular activity within hair follicles

Unlike many traditional therapies, Revian is non-invasive and can be used at home, making it easier for patients to stay consistent with treatment.

Reduced Risk for Patients

Revian offers a 100% money-back satisfaction guarantee, which significantly lowers the barrier for patients considering new treatment options. In addition, Revian is FSA-eligible, making it easier for many patients to use remaining healthcare funds.

What This Means for Patients

For individuals living with CCCA or other difficult hair loss conditions, these findings provide something that has been in short supply: data-driven optimism.

While no single therapy works for everyone, Revian’s growing body of research supports its role as part of a comprehensive, medically guided hair loss plan.

👉 If you have questions about Revian or want to know if it’s right for you, HPI Hair Partners is here to help.

Back to blog